Satellite Healthcare, San Jose, California, USA.
Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA.
Hemodial Int. 2022 Jul;26(3):435-448. doi: 10.1111/hdi.13013. Epub 2022 Apr 19.
Increased patient activation is associated with improved health outcomes; however, little is known about patient activation in people with end-stage kidney disease at the start of their dialysis journey. This study aimed to measure activation status changes over the first 4 months of dialysis.
Prospective, longitudinal, and observational study. Incident patients initiating dialysis at 25 in-center hemodialysis and 17 home dialysis programs across three US states managed by the same dialysis provider completed the 13-item Patient Activation Measure (PAM-13) survey at baseline (month 1 after commencement of dialysis) and follow-up (month 4). The survey yields a score (0-100) that corresponds to four levels (1-4), with higher scores or levels indicating higher activation.
One hundred eighty-two participants (139 center, 43 home) completed both baseline and follow-up surveys. Mean age was 60 ± 15 years, 40% female. Mean PAM-13 scores were 65.1 ± 16.8 and 64.8 ± 17.8 at baseline and follow-up, respectively; mean intraindividual change: -0.3 ± 17.3. The proportions of patients at levels 1-4 at baseline were 11%, 23%, 35%, and 31% respectively. At follow-up, 50%, 64%, 52%, and 37% of participants at levels 1-4, respectively, changed to a different PAM level (Spearman correlation = 0.47; p < 0.001). Home dialysis was associated with higher PAM scores when compared to in-center hemodialysis in multivariable analyses, adjusted for sociodemographic variables, comorbidities, and predialysis nephrology care (β = 5.74, 95% confidence intervals [CI]: 0.11-11.37 and 9.02, 95% CI: 3.03-15.02, at baseline and follow-up, respectively).
Although aggregated group scores and levels remained stable, intra-individual patient activation changed significantly during the first 4 months of dialysis. This novel finding is foundational to future projects aiming to design interventions to improve patient activation.
患者的激活程度与健康结果的改善相关;然而,在开始透析之旅的终末期肾病患者中,关于患者激活的信息知之甚少。本研究旨在测量透析开始后 4 个月内的激活状态变化。
这是一项前瞻性、纵向和观察性研究。在三个美国州的 25 个中心血液透析和 17 个家庭透析项目中,由同一家透析提供商管理的新开始透析的患者完成了 13 项患者激活量表(PAM-13)调查,分别在基线(透析开始后 1 个月)和随访(第 4 个月)时进行。该调查产生了一个(0-100)的分数,对应四个水平(1-4),分数或水平越高表示激活程度越高。
182 名参与者(中心 139 名,家庭 43 名)完成了基线和随访调查。平均年龄为 60±15 岁,40%为女性。基线和随访时的平均 PAM-13 评分为 65.1±16.8 和 64.8±17.8;个体内平均变化为-0.3±17.3。基线时处于 1-4 级的患者比例分别为 11%、23%、35%和 31%。在随访时,分别有 50%、64%、52%和 37%的参与者在 1-4 级之间转换为不同的 PAM 级别(Spearman 相关系数为 0.47;p<0.001)。多变量分析调整了社会人口统计学变量、合并症和透析前肾病护理后,与中心血液透析相比,家庭透析与更高的 PAM 评分相关,基线和随访时的差异分别为β=5.74(95%置信区间 [CI]:0.11-11.37)和 9.02(95%CI:3.03-15.02)。
尽管总体评分和水平保持稳定,但在透析的前 4 个月内,个体患者的激活程度发生了显著变化。这一新颖的发现是未来旨在设计提高患者激活干预措施的项目的基础。